The Molecular Oncology of Drug Resistance: Targets, Drugs and Chemical Biology-Reference-Cited by-同舟云学术

The Molecular Oncology of Drug Resistance: Targets, Drugs and Chemical Biology

Published:2019-12-02 Issue:33 Volume:26 Page:6018-6019
ISSN:0929-8673
Container-title:Current Medicinal Chemistry
language:en
Short-container-title:CMC

Author:

Beretta Giovanni Luca¹

Affiliation:

1. Department of Applied Research and Technological Development Molecular Pharmacology Unit Fondazione IRCCS Istituto Nazionale dei Tumori Via Amadeo 42, 20133 Milan, Italy

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry

Reference6 articles.

1. El Hassouni B.; Sarkisjan D.; Vos J.C.; Giovannetti E.; Peters G.J.; Targeting the ribosome biogenesis key molecule fibrillarin to avoid chemoresistance. Curr Med Chem 2019,26(33),6020-6032

2. Zanforlin E.; Zagotto G.; Ribaudo G.A.; Chemical approach to overcome tyrosine kinase inhibitors resistance : learning from chronic myeloid leukemia. Curr Med Chem 2019,26(33),6033-6052

3. Ferroni C.; Varchi G.; Non-steroidal androgen receptor antagonists and prostate cancer: a survey on chemical structures binding this fast-mutating target. Curr Med Chem 2019,26(33),6053-6073

4. Stankovic T.; Dinic J.; Podolski-Renic A.; Musso L.; Buric S.S.; Dallavalle S.; Pesic M.; Dual inhibitors as a new challenge for cancer multidrug resistance treatment. Curr Med Chem 2019,26(33),6074-6106

5. Guo J.; Mattos B.D.; Tardy B.L.; Moody V.M.; Xiao G.; Ejima H.; Cui J.; Liang K.; Richardson J.J.; Porous inorganic and hybrid systems for drug delivery: future promise in combatting drug resistance and translation to botanical applications. Curr Med Chem 2019,26(33),6107-6131

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lapatinib as a Dual Tyrosine Kinase Inhibitor Unexpectedly Activates Akt in MDA-MB-231 Triple-Negative Breast Cancer Cells;Letters in Drug Design & Discovery;2020-07-29